Biodistribution of phenylboric acid derivative entrapped lipiodol and 4-borono-2-18F-fluoro-L-phenylalanine-fructose in GP7TB liver tumor bearing rats for BNCT

Appl Radiat Isot. 2010 Mar;68(3):422-6. doi: 10.1016/j.apradiso.2009.12.033. Epub 2009 Dec 23.

Abstract

A new phenylboric acid derivative entrapped lipiodol (PBAD-lipiodol) was developed as a boron carrier for the boron neutron capture therapy (BNCT) of hepatoma in Taiwan. The biodistribution of both PBAD-lipiodol and BPA-fructose was assayed in GP7TB hepatoma-bearing rat model. The highest uptake of PBAD-lipiodol was found at 2h post injection. The application of BNCT for the hepatoma treatment in tumor-bearing rats is suggested to be 2-4h post PBAD-lipiodol injection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Boron Neutron Capture Therapy / methods*
  • Boronic Acids / chemical synthesis
  • Boronic Acids / pharmacokinetics*
  • Boronic Acids / pharmacology
  • Fluorine Radioisotopes / pharmacokinetics*
  • Fluorine Radioisotopes / pharmacology
  • Iodized Oil / chemical synthesis
  • Iodized Oil / pharmacokinetics*
  • Iodized Oil / pharmacology
  • Liver Neoplasms, Experimental / metabolism*
  • Liver Neoplasms, Experimental / radiotherapy
  • Magnetic Resonance Imaging
  • Male
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / chemical synthesis
  • Phenylalanine / pharmacokinetics
  • Phenylalanine / physiology
  • Rats
  • Rats, Inbred F344
  • Tissue Distribution

Substances

  • Boronic Acids
  • Fluorine Radioisotopes
  • Phenylalanine
  • Iodized Oil